Notice: Function Elementor\Core\Experiments\Manager::warn_removed_or_hidden_dependency was called incorrectly. Feature mega-menu depends on hidden experiment nested-elements. Please see Debugging in WordPress for more information. (This message was added in version 4.3.4.) in /home1/ocasiusm/medwire.ai/wp-includes/functions.php on line 6260
News – Medwire
Subscribe

Latest News

Sharing the voices of leaders and innovators shaping the future of healthcare.

InspireMD has secured approximately $58 million to fuel its next...
Sava Secures $19M to Advance Pain-Free CGM
Tandem Diabetes Care Warns of Insulin Pump Speaker Malfunction
J&J Ethicon Issues Correction for Surgical Stapler Cartridge Lockout
InspireMD has secured approximately $58 million to fuel its next growth phase, while strengthening its leadership with a major board addition.
InspireMD has secured approximately $58 million to fuel its next growth phase, while strengthening its leadership with a major board addition.
The funding includes a $40.1M PIPE led by OrbiMed and Marshall Wace, plus $17.9M from warrant exercises. Proceeds will support operations as the company launches its FDA-approved CGuard Prime carotid stent in the U.S....
Read More

More on this topic

Linkedin

Get the MEDWIRE.AI Newsletter

Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.

© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.

Subscribe